Insider · CIK 0001711517

Lavino Francesco Maria

Reports to the SEC for 2 companies · KING OF PRUSSIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001711517

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-09-30	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−366 sh	$0.53	−$195.078	185,393
2020-08-31	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−366 sh	$0.62	−$226.7	185,759
2020-08-20	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−3,759 sh	$0.65	−$2,434.328	186,125
2020-08-19	Nabriva Therapeutics plcM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+11.3K sh	—	—	189,884
2020-08-19	Nabriva Therapeutics plcRestricted Share UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−11.3K sh	—	—	0
2020-07-31	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−366 sh	$0.76	−$278.16	178,634
2020-06-30	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−366 sh	$0.67	−$246.904	179,000
2020-05-31	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−366 sh	$1.14	−$417.24	179,366
2020-04-30	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−366 sh	$0.55	−$200.678	179,732
2020-03-31	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−366 sh	$0.57	−$210.45	180,098
2020-02-28	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−366 sh	$1.35	−$494.1	180,464
2020-02-06	Nabriva Therapeutics plcA Award	Chief Commercial Officer	AAward	+105K sh	—	—	180,830
2020-02-06	Nabriva Therapeutics plcStock OptionsA Award	Chief Commercial Officer	AAward	+210K sh	—	—	210,000
2020-01-31	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−3,892 sh	$1.35	−$5,254.2	75,830
2019-08-22	Nabriva Therapeutics plcP Purchase	Chief Commercial Officer	PPurchase	+4,800 sh	$2.04	+$9,780	15,972
2019-08-21	Nabriva Therapeutics plcS Sale	Chief Commercial Officer	SSale	−3,797 sh	$2.08	−$7,897.76	11,172
2019-08-21	Nabriva Therapeutics plcF Tax Payment	Chief Commercial Officer	FTax Payment	−3,797 sh	$2.08	−$7,897.76	11,172
2019-08-19	Nabriva Therapeutics plcM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+11.3K sh	—	—	14,969
2019-08-19	Nabriva Therapeutics plcRestricted Share UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−11.3K sh	—	—	11,250
2019-01-31	Nabriva Therapeutics plcStock OptionsA Award	Chief Commercial Officer	AAward	+138K sh	—	—	138,200
2019-01-31	Nabriva Therapeutics plcRestricted Stock UnitsA Award	Chief Commercial Officer	AAward	+52.5K sh	—	—	52,500
2018-05-23	Nabriva Therapeutics plcP Purchase	Chief Commercial Officer	PPurchase	+2,160 sh	$4.60	+$9,936	3,719
2018-01-31	Nabriva Therapeutics plcStock OptionsA Award	Chief Commercial Officer	AAward	+100K sh	—	—	100,000
2018-01-31	Nabriva Therapeutics plcRestricted Stock UnitsA Award	Chief Commercial Officer	AAward	+22.5K sh	—	—	22,500
2017-11-29	Nabriva Therapeutics plcP Purchase	Chief Commercial Officer	PPurchase	+1,569 sh	$6.29	+$9,869.01	1,569
2017-07-31	Nabriva Therapeutics plcStock OptionA Award	Chief Commercial Officer	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Oct 14
Lavino Francesco Maria0001104659-20-111076
SEC(opens sec.gov)
Sep 24
Lavino Francesco Maria0001104659-20-101907
SEC(opens sec.gov)
Aug 214
Lavino Francesco Maria0001104659-20-097719
SEC(opens sec.gov)
Aug 44
Lavino Francesco Maria0001104659-20-090283
SEC(opens sec.gov)
Jul 24
Lavino Francesco Maria0001104659-20-080542
SEC(opens sec.gov)
Jun 34
Lavino Francesco Maria0001104659-20-069179
SEC(opens sec.gov)
May 44
Lavino Francesco Maria0001104659-20-056348
SEC(opens sec.gov)
Apr 24
Lavino Francesco Maria0001104659-20-042581
SEC(opens sec.gov)
Mar 34
Lavino Francesco Maria0001104659-20-028848
SEC(opens sec.gov)
Feb 104
Lavino Francesco Maria0001104659-20-015173
SEC(opens sec.gov)
Feb 44
Lavino Francesco Maria0001104659-20-010899
SEC(opens sec.gov)
Aug 264/A
Lavino Francesco Maria0001104659-19-047347
SEC(opens sec.gov)
Aug 264
Lavino Francesco Maria0001104659-19-047352
SEC(opens sec.gov)
Aug 214
Lavino Francesco Maria0001104659-19-046855
SEC(opens sec.gov)
Feb 44
Lavino Francesco Maria0001104659-19-005521
SEC(opens sec.gov)

Companies

Address

1000 CONTINENTAL DRIVE SUITE 600

KING OF PRUSSIA, PA, 19406